CD79A and hepatocellular carcinoma: Subgroup analysis (Table 3) showed that rOD of EBNA1-IgA remained associated with increased risk of primary liver cancer among males (adjusted OR: 1.55, 95% CI: 1.13, 2.14) and with increased risk of HCC specifically (adjusted OR: 1.51, 95% CI: 1.10, 2.09).